Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways.
暂无分享,去创建一个
D. Caccia | I. Bongarzone | Dario Caccia | Laura Zanetti Domingues | Francesca Miccichè | Maida De Bortoli | Cristiana Carniti | Piera Mondellini | Italia Bongarzone | P. Mondellini | M. De Bortoli | C. Carniti | F. Miccichè | Laura Zanetti Domingues | Dario Caccia
[1] Apurva A Desai,et al. Sorafenib in advanced clear-cell renal-cell carcinoma. , 2007, The New England journal of medicine.
[2] K. Goddard,et al. HER2 Evaluation and Its Impact on Breast Cancer Treatment Decisions , 2011, Public Health Genomics.
[3] R. Montironi,et al. The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. , 2011, Future oncology.
[4] S. Werner,et al. Active Caspase-1 Is a Regulator of Unconventional Protein Secretion , 2008, Cell.
[5] P. Nelson,et al. Molecular Alterations in Prostate Carcinomas that Associate with In vivo Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15 , 2007, Clinical Cancer Research.
[6] I. Arnaud,et al. Protein fractionation in a multicompartment device using Off‐Gel™ isoelectric focusing , 2003, Electrophoresis.
[7] N. Kyprianou,et al. Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma. , 2011, European urology.
[8] C. Sawyers. The cancer biomarker problem , 2008, Nature.
[9] A. Villa,et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. , 2006, Cancer research.
[10] J. Baselga,et al. Targeting Tyrosine Kinases in Cancer: The Second Wave , 2006, Science.
[11] O. Wagner,et al. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. , 2009, Journal of proteome research.
[12] J. Rossier,et al. Proteome analysis of human plasma and amniotic fluid by Off‐Gel™ isoelectric focusing followed by nano‐LC‐MS/MS , 2006, Electrophoresis.
[13] Troels Z. Kristiansen,et al. Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*S , 2006, Molecular & Cellular Proteomics.
[14] S. Brunak,et al. Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.
[15] W. Zhong,et al. CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value , 2009, Cancer investigation.
[16] A. Vlahou,et al. Secretome proteomics for discovery of cancer biomarkers. , 2010, Journal of proteomics.
[17] Maria P. Pavlou,et al. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology , 2010, Molecular oncology.
[18] W. D. Fairlie,et al. Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1 , 2007, Nature Medicine.
[19] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[20] D. Brown,et al. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage , 2004, The Lancet.
[21] M. Clynes,et al. Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of disease‐specific biomarkers , 2011, Proteomics.
[22] M. Lai,et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. , 2010, Journal of proteome research.
[23] David H Perlman,et al. Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. , 2009, Analytical chemistry.
[24] S. Razavi,et al. Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia , 2009, Leukemia & lymphoma.
[25] Maria P. Pavlou,et al. The cancer cell secretome: a good source for discovering biomarkers? , 2010, Journal of proteomics.
[26] Sang‐Gun Ahn,et al. Sox4 stimulates ß-catenin activity through induction of CK2. , 2011, Oncology reports.
[27] Hsueh-Kung Lin,et al. Unique patterns of molecular profiling between human prostate cancer LNCaP and PC‐3 cells , 2009, The Prostate.
[28] N. Blom,et al. Feature-based prediction of non-classical and leaderless protein secretion. , 2004, Protein engineering, design & selection : PEDS.
[29] P. Allavena,et al. Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks. , 2010, Journal of proteome research.
[30] Paul Tempst,et al. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes. , 2009, Journal of proteome research.
[31] H. Clevers,et al. Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.
[32] F. Sinicrope,et al. Targeted therapeutic agents for colorectal cancer. , 2010, Gastroenterology clinics of North America.
[33] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[34] S. Brunak,et al. SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .
[35] S. Mathivanan,et al. ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.
[36] Frank McCormick,et al. The molecular pathology of cancer , 2010, Nature Reviews Clinical Oncology.